Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000144928 | SCV003445740 | uncertain significance | Amyotrophic lateral sclerosis type 15 | 2022-06-12 | criteria provided, single submitter | clinical testing | This variant disrupts the p.Pro497 amino acid residue in UBQLN2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21857683, 24215460, 25398946, 30348461). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 157594). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 24771548). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 497 of the UBQLN2 protein (p.Pro497Leu). |
OMIM | RCV000144928 | SCV000191924 | pathogenic | Amyotrophic lateral sclerosis type 15 | 2014-05-01 | no assertion criteria provided | literature only |